Insider Trading & Ownership - Doyle Anthony

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Doyle Anthony
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-15
Sale
2022-12-19
4:55 pm
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
5,700$10.9$62,130163,966
(Direct)
View
2021-11-23
Purchase
2021-11-24
6:35 pm
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
35,258$12.48$440,02093,719
(Direct)
View
2020-08-11
Purchase
2020-08-12
4:31 pm
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
54,000$4.08$220,32054,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-19
Tax Withholding
2023-12-20
4:35 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
2,482$6.05227,444
(Direct)
View
2023-12-14
Option Award
2023-12-18
4:37 pm
2024-12-14
2033-12-14
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
192,500$0388,426
(Direct)
View
2023-12-14
Tax Withholding
2023-12-18
4:37 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
5,475$6.43388,426
(Direct)
View
2022-12-19
Option Award
2022-12-21
4:32 pm
2023-12-19
2032-12-19
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
192,500$0356,466
(Direct)
View
2021-12-14
Option Award(A)
2022-01-13
4:40 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
75,000$0168,719
(Direct)
View
2021-12-14
Option Award
2021-12-16
4:59 pm
2022-12-14
2031-12-14
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
279,000$0372,719
(Direct)
View
2020-12-15
Option Award
2020-12-17
4:23 pm
2021-12-15
2030-12-15
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
332,500$0332,500
(Direct)
View
2020-04-30
Option Award
2020-05-04
4:08 pm
2021-04-30
2020-04-30
BIOCRYST PHARMACEUTICALS INCBCRXDoyle Anthony
Chief Financial Officer
600,000$0600,000
(Direct)
View
(A) Indicate amendment filing.